MedTrace Logo

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

NCT00414583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2021-04-09

No results posted yet for this study

Summary

More than one million people in Europe suffer from a stroke every day. Normally older people have a stroke, but also a significant number of younger people between 18 and 55 years. Usually, these cannot be explained by the classical risk factors such as diabetes, overweight and high blood pressure. New studies indicate that in about 1 - 2 % of the younger stroke patients the cause could have been an undiagnosed genetic disease, the so called Fabry disease. The purpose of this study is to determine in a large number of young stroke patients, how many strokes were caused by Fabry Disease.

Conditions

  • Cerebrovascular Accident

Interventions

OTHER

No intervention

Observational study, only laboratory analysis and diagnostic interventions done; no drug tested

Sponsors & Collaborators

  • Shire Human Genetic Therapies, Inc.

    collaborator INDUSTRY

  • CENTOGENE GmbH Rostock

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Austria
  • Belgium
  • Croatia
  • Finland
  • France
  • Georgia
  • Germany
  • Ireland
  • Italy
  • Malta
  • Poland
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00414583 on ClinicalTrials.gov